Clinical Trial

A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This Phase I clinical trial will investigate the relative bioavailability between two formulations of HRS-1893 tablets and the influence of food on the drug's pharmacokinetics in healthy adult participants. The safety and tolerability of HRS-1893 will also be monitored.
Protocol Amendment History 3 changes
critical Trial completed 2026-04-03
notable Primary completion pushed: 2026-02 -> 2026-03-21 2026-04-03
minor Completion pushed: 2026-02 -> 2026-03-21 2026-04-03
Trial Details
NCT Number NCT07272330
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Cardiomyopathy
Enrollment 38 participants
Start Date 2025-12-11
Primary Completion 2026-03-21 (estimated)
Study Completion 2026-03-21 (estimated)
Updated on ClinicalTrials.gov 2026-04-02